Owlet (OWLT) Revenue & Revenue Breakdown
Owlet Revenue Highlights
Latest Revenue (Y)
$105.70M
Latest Revenue (Q)
$22.50M
Main Geography (Y)
UNITED STATES
Owlet Revenue by Period
Owlet Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $105.70M | 35.42% |
| 2024-12-31 | $78.06M | 44.52% |
| 2023-12-31 | $54.01M | -21.95% |
| 2022-12-31 | $69.20M | -8.76% |
| 2021-12-31 | $75.84M | 0.58% |
| 2020-12-31 | $75.40M | 51.41% |
| 2019-12-31 | $49.80M | - |
Owlet generated $105.70M in revenue during NA 2025, up 35.42% compared to the previous quarter, and up 140.18% compared to the same period a year ago.
Owlet Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $22.50M | -15.26% |
| 2025-12-31 | $26.55M | -16.99% |
| 2025-09-30 | $31.99M | 22.73% |
| 2025-06-30 | $26.06M | 23.50% |
| 2025-03-31 | $21.10M | 2.95% |
| 2024-12-31 | $20.50M | -7.33% |
| 2024-09-30 | $22.12M | 6.87% |
| 2024-06-30 | $20.70M | 40.33% |
| 2024-03-31 | $14.75M | -29.78% |
| 2023-12-31 | $21.00M | 128.75% |
| 2023-09-30 | $9.18M | -29.84% |
| 2023-06-30 | $13.09M | 21.91% |
| 2023-03-31 | $10.74M | -10.20% |
| 2022-12-31 | $11.96M | -31.13% |
| 2022-09-30 | $17.36M | -5.39% |
| 2022-06-30 | $18.35M | -14.81% |
| 2022-03-31 | $21.54M | -957.40% |
| 2021-12-31 | $-2.51M | -107.97% |
| 2021-09-30 | $31.50M | 26.33% |
| 2021-06-30 | $24.94M | 13.81% |
| 2021-03-31 | $21.91M | 4.35% |
| 2020-12-31 | $21.00M | -0.81% |
| 2020-09-30 | $21.17M | 15.27% |
| 2020-06-30 | $18.36M | 23.50% |
| 2020-03-31 | $14.87M | - |
Owlet generated $22.50M in revenue during Q1 2026, up -15.26% compared to the previous quarter, and up 109.76% compared to the same period a year ago.
Owlet Revenue Breakdown
Owlet Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Non-US | $13.28M | $9.94M | $7.65M | $11.23M | $10.40M |
| UNITED STATES | $86.52M | $62.93M | $46.36M | $57.97M | $65.44M |
Latest
Owlet's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (86.70%), and Non-US (13.30%).
Quarterly Revenue by Country
| Country | Dec 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-US | $9.59M | $1.12M | $2.56M | $3.17M | $2.23M | $2.70M | $1.85M | $3.36M | $1.83M | $1.25M | $1.19M | $3.82M | $2.11M | $2.47M | $2.83M | $3.92M | $3.33M |
| UNITED STATES | $44.94M | $24.25M | $17.33M | $15.61M | $18.53M | $15.89M | $12.90M | $17.64M | $7.35M | $11.83M | $9.54M | $8.13M | $15.25M | $15.88M | $18.71M | $-6.43M | $28.17M |
Latest
Owlet's latest quarterly revenue breakdown by geography, as of Dec 25: UNITED STATES (82.41%), and Non-US (17.59%).
Owlet Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LUCD | Lucid Diagnostics | $4.71B | $1.26B |
| ANIK | Anika Therapeutics | $112.82M | $29.61M |
| OWLT | Owlet | $105.70M | $22.50M |
| LNSR | LENSAR | $58.44M | $13.43M |
| RPID | Rapid Micro Biosystems | $33.59M | $7.84M |
| MXCT | MaxCyte | $33.03M | $9.65M |
| AVR | Anteris Technologies Global | $1.91M | $494.00K |
| ELTX | Elicio Therapeutics | - | - |
| CRBP | Corbus Pharmaceuticals | - | - |
| CRDF | Cardiff Oncology | - | - |